by Brenda Baletti, Ph.D., Childrens Health Defense:
The study, published by the American Academy of Child & Adolescent Psychiatry in its journal, JAACAP, actually found that paroxetine (Paxil) was neither safe nor effective. Internal documents later showed that GSK hired a PR firm to ghostwrite the article, cherry-picking data and recruiting 20 co-authors to lend credibility. The company then used the paper to market Paxil to doctors.
TRUTH LIVES on at https://sgtreport.tv/
The publisher of a decades-old peer-reviewed article claiming that the antidepressant paroxetine, marketed as Paxil, is safe and effective for teens, said it is reviewing the article.
Meanwhile, a lawsuit filed last month against the American Academy of Child & Adolescent Psychiatry (AACAP) and Elsevier, which publishes the organization’s journal, JAACAP, demands that the journal retract the article.
Attorney George W. Murgatroyd III, acting on behalf of the public, filed the suit in the Superior Court of the District of Columbia Civil Division.
Published in 2001, the article ignited decades of controversy. Critics say it overstated Paxil’s benefits and downplayed its risks, including increased suicide risk among teens.
Known as the “Keller article,” after lead author Dr. Martin Keller, then chair of psychiatry at Brown University, the paper reported partial results from Study 329, an investigation into whether paroxetine was safe and effective for treating depression in adolescents.
GlaxoSmithKline, now GSK, which manufactures Paxil, funded the study.
The article reported that “paroxetine is generally well tolerated and effective for major depression in adolescents” — a claim now widely known to have been based on distorted results.
The study actually found the drug was neither safe nor effective. Internal documents later showed that GSK hired a PR firm to ghostwrite the article, cherry-picking data and recruiting 20 co-authors to lend credibility. The company then used the paper to market Paxil to doctors.
Read More @ ChildrensHealthDefense.org
